Lipid profile of circulating placental extracellular vesicles during pregnancy identifies foetal growth restriction risk
Journal of Extracellular Vesicles · 2024-02 · 13 (2)
DOI: 10.1002/jev2.12413 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 14.02.2024. Verfasst von Miira M Klemetti und 11 weiteren Autor:innen. Beteiligte Einrichtung: Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Fetal Growth Retardation, Extracellular Vesicles. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, Canada Research Chairs, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Small‐for‐gestational age (SGA) neonates exhibit increased perinatal morbidity and mortality, and a greater risk of developing chronic diseases in adulthood. Currently, no effective maternal blood‐based screening methods for determining SGA risk are available. We used a high‐resolution MS/MS ALL shotgun lipidomic approach to explore the lipid profiles of small extracellular vesicles (sEV) released from the placenta into the circulation of pregnant individuals. Samples were acquired from 195 normal and 41 SGA pregnancies. Lipid profiles were determined serially across pregnancy. We identified specific lipid signatures of placental sEVs that define the trajectory of a normal pregnancy and their changes occurring in relation to maternal characteristics (parity and ethnicity) and birthweight centile. We constructed a multivariate model demonstrating that specific lipid features of circulating placental sEVs, particularly during early gestation, are highly predictive of SGA infants. Lipidomic‐based biomarker development promises to improve the early detection of pregnancies at risk of developing SGA, an unmet clinical need in obstetrics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
- Department of Obstetrics & Gynecology, University of Toronto, Toronto, Ontario, Canada.
- Program in Translational Medicine, Peter Gilgan Centre for Research and Learning, Hospital for Sick Children, Toronto, Ontario, Canada.
- Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Canada.
- Placental Research Group LLC, Maplewood, New Jersey, USA.
- Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Isabella Caniggia
Förderung
- NICHD NIH HHS
- Canada Research Chairs
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Klemetti, M. M., Pettersson, A. B. V., Ahmad Khan, A., Ermini, L., Porter, T. R., Litvack, M. L., Alahari, S., Zamudio, S., Illsley, N. P., Röst, H., Post, M., & Caniggia, I. (2024). Lipid profile of circulating placental extracellular vesicles during pregnancy identifies foetal growth restriction risk. Journal of Extracellular Vesicles, 13(2). https://doi.org/10.1002/jev2.12413
Vancouver
Klemetti MM, Pettersson ABV, Ahmad Khan A, Ermini L, Porter TR, Litvack ML, et al. Lipid profile of circulating placental extracellular vesicles during pregnancy identifies foetal growth restriction risk. Journal of Extracellular Vesicles. 2024;13(2). doi:10.1002/jev2.12413
BibTeX
@article{Klemetti2024,
author = {Klemetti, Miira M and Pettersson, Ante B V and Ahmad Khan, Aafaque and Ermini, Leonardo and Porter, Tyler R and Litvack, Michael L and Alahari, Sruthi and Zamudio, Stacy and Illsley, Nicholas P and Röst, Hannes and Post, Martin and Caniggia, Isabella},
title = {Lipid profile of circulating placental extracellular vesicles during pregnancy identifies foetal growth restriction risk},
journal = {Journal of Extracellular Vesicles},
year = {2024},
volume = {13},
number = {2},
doi = {10.1002/jev2.12413}
}
EUVIMED